M&A Transaction Database
Oncology M&A Transactions
Mergers and acquisitions in the Oncology subsector.
Never miss a transaction
Get instant notifications when new M&A transactions matching "Oncology" are published.
Filters
3 shown
DateTransactionAcquirerDeal ValueCountry
Date:May 11, 2026
Eli Lilly Acquires CAR-T Firm Kelonia for $3.25 Billion
Eli Lilly's $3.25B acquisition of Kelonia Therapeutics bolsters its oncology pipeline with advanced CAR-T technology. Learn about this strategic biotech deal.
Acquirer:Eli Lilly
Deal Value:n/a
Country:🇺🇸
Date:May 7, 2026
Merck Acquires Terns Pharmaceuticals for $5.8 Billion
Merck strengthens its oncology pipeline by acquiring Terns Pharmaceuticals for $5.8 billion, adding a promising CML treatment candidate.
Acquirer:Merck
Deal Value:n/a
Country:🇺🇸
Date:May 6, 2026
Azra AI Acquires Thynk Health for Oncology Workflow
Azra AI enhances its healthcare platform by acquiring Thynk Health, boosting cancer care coordination and incidental findings management for hospitals nationwide.
Acquirer:Azra AI
Deal Value:n/a
Country:🇺🇸
Never Miss a Deal
Get weekly investment intelligence. Free forever.
You reached the end (3 deals).